News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-21 8:59:18 am IFRX Stock Earnings: InflaRx Misses EPS, Misses Revenue for Q4 2023 InvestorPlace
2024-03-21 5:45:2 am InflaRx N.V. (IFRX) Reports Q4 Loss, Misses Revenue Estimates Zacks
2024-03-21 4:0:0 am InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans GlobeNewswire
2024-03-19 4:30:0 am InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024 GlobeNewswire
2024-03-06 2:27:50 am Is InflaRx (NASDAQ:IFRX) In A Good Position To Deliver On Growth Plans? Simply Wall St.
2024-02-22 4:30:0 am InflaRx Appoints Jan Medina as Head of Investor Relations GlobeNewswire
2024-01-25 4:30:0 am InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients GlobeNewswire
2024-01-25 2:30:14 am InflaRx N.V.'s (NASDAQ:IFRX) top owners are individual investors with 55% stake, while 23% is held by institutions Simply Wall St.
2024-01-04 4:0:0 am InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904 GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information